CORCEPT THERAPEUTICS, INC. – Trademark Portfolio

Entity Type: 03

CORCEPT THERAPEUTICS, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include KORLYM and CORCEPT. The owner is based in MENLO PARK, CA.

149 COMMONWEALTH DRIVE

MENLO PARK, CA 94025

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CORCEPT
CORCEPT
Registered 2015
KORLYM
KORLYM
Abandoned 2015
CORLUXIN
CORLUXIN
Abandoned 2013
KORLYM
KORLYM
Registered 2011
CORLUXIN
CORLUXIN
Abandoned 2011
CORCEPT
CORCEPT
Cancelled 2001
CORLUX
CORLUX
Cancelled 2001

Trademark Classifications

CORCEPT THERAPEUTICS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CORCEPT THERAPEUTICS, INC. have?

CORCEPT THERAPEUTICS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 2 cancelled.

What trademark classes does CORCEPT THERAPEUTICS, INC. file in?

CORCEPT THERAPEUTICS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CORCEPT THERAPEUTICS, INC.'s most well-known trademarks?

CORCEPT THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as KORLYM and CORCEPT. These are among 2 currently registered trademarks in the portfolio.

What is CORCEPT THERAPEUTICS, INC.'s trademark registration success rate?

CORCEPT THERAPEUTICS, INC. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.